Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies.
Vitamin d and multiple sclerosis.
Transplantation of Human Adipose-Derived Stem Cells Enhances Remyelination in Lysolecithin-Induced Focal Demyelination of Rat Spinal Cord.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Magnetic Resonance Imaging in Balo's Concentric Sclerosis. A Case Report.
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis.
A review of the sheep-multiple sclerosis connection.
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis.
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.
Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro.
Importance of Human Leukocyte Antigen (HLA) Class I and II Alleles on the Risk of Multiple Sclerosis.
Multiple sclerosis: a comprehensive review for the physician assistant.
Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients.
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
170
171
172
173
174
175
176
177
178
…
next ›
last »